329 related articles for article (PubMed ID: 9399962)
1. Activators of peroxisome proliferator-activated receptor gamma have depot-specific effects on human preadipocyte differentiation.
Adams M; Montague CT; Prins JB; Holder JC; Smith SA; Sanders L; Digby JE; Sewter CP; Lazar MA; Chatterjee VK; O'Rahilly S
J Clin Invest; 1997 Dec; 100(12):3149-53. PubMed ID: 9399962
[TBL] [Abstract][Full Text] [Related]
2. Regional differences in the response of human pre-adipocytes to PPARgamma and RXRalpha agonists.
Sewter CP; Blows F; Vidal-Puig A; O'Rahilly S
Diabetes; 2002 Mar; 51(3):718-23. PubMed ID: 11872672
[TBL] [Abstract][Full Text] [Related]
3. Use of a PPAR gamma-specific monoclonal antibody to demonstrate thiazolidinediones induce PPAR gamma receptor expression in vitro.
Su JL; Winegar DA; Wisely GB; Sigel CS; Hull-Ryde EA
Hybridoma; 1999 Jun; 18(3):273-80. PubMed ID: 10475242
[TBL] [Abstract][Full Text] [Related]
4. Thiazolidinedione exposure increases the expression of uncoupling protein 1 in cultured human preadipocytes.
Digby JE; Montague CT; Sewter CP; Sanders L; Wilkison WO; O'Rahilly S; Prins JB
Diabetes; 1998 Jan; 47(1):138-41. PubMed ID: 9421389
[TBL] [Abstract][Full Text] [Related]
5. A novel method for analysis of nuclear receptor function at natural promoters: peroxisome proliferator-activated receptor gamma agonist actions on aP2 gene expression detected using branched DNA messenger RNA quantitation.
Burris TP; Pelton PD; Zhou L; Osborne MC; Cryan E; Demarest KT
Mol Endocrinol; 1999 Mar; 13(3):410-7. PubMed ID: 10076998
[TBL] [Abstract][Full Text] [Related]
6. Peroxisome proliferator-activated receptor gamma1 (PPARgamma1) expresses in rat mesangial cells and PPARgamma agonists modulate its differentiation.
Asano T; Wakisaka M; Yoshinari M; Iino K; Sonoki K; Iwase M; Fujishima M
Biochim Biophys Acta; 2000 Jun; 1497(1):148-54. PubMed ID: 10838168
[TBL] [Abstract][Full Text] [Related]
7. 15-Deoxy-delta(12,14) prostaglandin J2: a putative endogenous promoter of adipogenesis suppresses the ob gene.
Sinha D; Addya S; Murer E; Boden G
Metabolism; 1999 Jun; 48(6):786-91. PubMed ID: 10381155
[TBL] [Abstract][Full Text] [Related]
8. Ligand for peroxisome proliferator-activated receptor gamma (troglitazone) has potent antitumor effect against human prostate cancer both in vitro and in vivo.
Kubota T; Koshizuka K; Williamson EA; Asou H; Said JW; Holden S; Miyoshi I; Koeffler HP
Cancer Res; 1998 Aug; 58(15):3344-52. PubMed ID: 9699665
[TBL] [Abstract][Full Text] [Related]
9. A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation.
Kliewer SA; Lenhard JM; Willson TM; Patel I; Morris DC; Lehmann JM
Cell; 1995 Dec; 83(5):813-9. PubMed ID: 8521498
[TBL] [Abstract][Full Text] [Related]
10. Peroxisome proliferator-activated receptor gamma ligands inhibit estrogen biosynthesis in human breast adipose tissue: possible implications for breast cancer therapy.
Rubin GL; Zhao Y; Kalus AM; Simpson ER
Cancer Res; 2000 Mar; 60(6):1604-8. PubMed ID: 10749129
[TBL] [Abstract][Full Text] [Related]
11. Magnitude of peroxisome proliferator-activated receptor-gamma activation is associated with important and seemingly opposite biological responses in breast cancer cells.
Clay CE; Namen AM; Atsumi G; Trimboli AJ; Fonteh AN; High KP; Chilton FH
J Investig Med; 2001 Sep; 49(5):413-20. PubMed ID: 11523697
[TBL] [Abstract][Full Text] [Related]
12. Enhancing effect of troglitazone on porcine adipocyte differentiation in primary culture: a comparison with dexamethasone.
Tchoukalova YD; Hausman DB; Dean RG; Hausman GJ
Obes Res; 2000 Dec; 8(9):664-72. PubMed ID: 11225715
[TBL] [Abstract][Full Text] [Related]
13. Thiazolidinediones inhibit osteoclast-like cell formation and bone resorption in vitro.
Okazaki R; Toriumi M; Fukumoto S; Miyamoto M; Fujita T; Tanaka K; Takeuchi Y
Endocrinology; 1999 Nov; 140(11):5060-5. PubMed ID: 10537132
[TBL] [Abstract][Full Text] [Related]
14. Peroxisome proliferator-activated receptor-gamma upregulates caveolin-1 and caveolin-2 expression in human carcinoma cells.
Burgermeister E; Tencer L; Liscovitch M
Oncogene; 2003 Jun; 22(25):3888-900. PubMed ID: 12813462
[TBL] [Abstract][Full Text] [Related]
15. Thiazolidinedione- and tumor necrosis factor alpha-induced downregulation of peroxisome proliferator-activated receptor gamma mRNA in differentiated 3T3-L1 adipocytes.
Perrey S; Ishibashi S; Yahagi N; Osuga J; Tozawa R; Yagyu H; Ohashi K; Gotoda T; Harada K; Chen Z; Iizuka Y; Shionoiri F; Yamada N
Metabolism; 2001 Jan; 50(1):36-40. PubMed ID: 11172472
[TBL] [Abstract][Full Text] [Related]
16. Expression of peroxisome proliferator-activated receptor gamma (PPARgamma) in rat aortic smooth muscle cells.
Iijima K; Yoshizumi M; Ako J; Eto M; Kim S; Hashimoto M; Sugimoto N; Liang YQ; Sudoh N; Toba K; Ouchi Y
Biochem Biophys Res Commun; 1998 Jun; 247(2):353-6. PubMed ID: 9642130
[TBL] [Abstract][Full Text] [Related]
17. Effects of rosiglitazone and linoleic acid on human preadipocyte differentiation.
Hutley LJ; Newell FM; Joyner JM; Suchting SJ; Herington AC; Cameron DP; Prins JB
Eur J Clin Invest; 2003 Jul; 33(7):574-81. PubMed ID: 12814394
[TBL] [Abstract][Full Text] [Related]
18. Thiazolidinedione induces the adipose differentiation of fibroblast-like cells resident within bovine skeletal muscle.
Torii SI; Kawada T; Matsuda K; Matsui T; Ishihara T; Yano H
Cell Biol Int; 1998; 22(6):421-7. PubMed ID: 10328850
[TBL] [Abstract][Full Text] [Related]
19. Regulation of the growth arrest and DNA damage-inducible gene 45 (GADD45) by peroxisome proliferator-activated receptor gamma in vascular smooth muscle cells.
Bruemmer D; Yin F; Liu J; Berger JP; Sakai T; Blaschke F; Fleck E; Van Herle AJ; Forman BM; Law RE
Circ Res; 2003 Aug; 93(4):e38-47. PubMed ID: 12881480
[TBL] [Abstract][Full Text] [Related]
20. Troglitazone effects on gene expression in human skeletal muscle of type II diabetes involve up-regulation of peroxisome proliferator-activated receptor-gamma.
Park KS; Ciaraldi TP; Lindgren K; Abrams-Carter L; Mudaliar S; Nikoulina SE; Tufari SR; Veerkamp JH; Vidal-Puig A; Henry RR
J Clin Endocrinol Metab; 1998 Aug; 83(8):2830-5. PubMed ID: 9709955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
